Real-Time Single Molecule Imaging Reveals Pathway-Selective Action of Aducanumab on Amyloid-β Aggregation
Nano Letters · 2026
DOI: 10.1021/acs.nanolett.6c02842 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, 2026. Verfasst von Takahiro Watanabe-Nakayama und 7 weiteren Autor:innen. Beteiligte Einrichtung: WPI Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kakuma-machi, Kanazawa920-1192, Japan. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Antibodies, Monoclonal, Humanized, Single Molecule Imaging, Peptide Fragments. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Kanazawa University, Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
Aducanumab is an anti-amyloid-β (Aβ) antibody that binds aggregated Aβ species and has been reported to inhibit secondary nucleation on fibril surfaces. However, how antibody binding influences aggregate dynamics at the molecular level remains incompletely understood. Here, we used high-speed atomic force microscopy (HS-AFM) to directly visualize the interactions between aducanumab and Aβ42 aggregates in real time at single-molecule resolution. Aducanumab extensively decorated oligomers, protofibrils, and fibrils, with fibril binding depending on local surface structure. Consistent with its reported inhibition of secondary nucleation, bulk thioflavin T assays showed slowed aggregation. Nevertheless, in the continued presence of the antibody, protofibril formation proceeded─a pathway distinct from secondary nucleation. These observations reveal a pathway-selective mode of action: extensive surface binding and the suppression of secondary nucleation do not extend to protofibril formation, which proceeds in the continued presence of the antibody.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- WPI Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kakuma-machi, Kanazawa920-1192, Japan.
- Department of Neurology, Graduate School of Medical Sciences, Kanazawa University, 13-1, Takara-machi, Kanazawa920-8640, Japan.
ORCID-Profile: Takahiro Watanabe-Nakayama, Kenichi Umeda, Hiroki Konno, Noriyuki Kodera, Toshio Ando, Kenjiro Ono
Förderung
- Kanazawa University
- Japan Society for the Promotion of Science
- Ministry of Education, Culture, Sports, Science and Technology
Zitieren
APA
Watanabe-Nakayama, T., Noguchi-Shinohara, M., Umeda, K., Muramatsu, D., Konno, H., Kodera, N., Ando, T., & Ono, K. (2026). Real-Time Single Molecule Imaging Reveals Pathway-Selective Action of Aducanumab on Amyloid-β Aggregation. Nano Letters. https://doi.org/10.1021/acs.nanolett.6c02842
Vancouver
Watanabe-Nakayama T, Noguchi-Shinohara M, Umeda K, Muramatsu D, Konno H, Kodera N, et al. Real-Time Single Molecule Imaging Reveals Pathway-Selective Action of Aducanumab on Amyloid-β Aggregation. Nano Letters. 2026. doi:10.1021/acs.nanolett.6c02842
BibTeX
@article{WatanabeNakayama2026,
author = {Watanabe-Nakayama, Takahiro and Noguchi-Shinohara, Moeko and Umeda, Kenichi and Muramatsu, Daiki and Konno, Hiroki and Kodera, Noriyuki and Ando, Toshio and Ono, Kenjiro},
title = {Real-Time Single Molecule Imaging Reveals Pathway-Selective Action of Aducanumab on Amyloid-β Aggregation},
journal = {Nano Letters},
year = {2026},
doi = {10.1021/acs.nanolett.6c02842}
}
EUVIMED